Redemplo (plozasiran) has been approved by the European Commission (EC) for use as an adjunct to diet to reduce TG levels in adult patients diagnosed with familial chylomicronaemia syndrome (FCS) according to clinical criteria or genetic testing.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
